. I knew zero about the fundamentals of IXC. Currency in USD 38. 5¢ INVEX THERAPEUTICS LTD - Discussion. , page-3. , page-3. 05. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. ASX - By Stock. Market . Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. ASX - By Stock. rights. Quarterly Activities/Appendix 4C Cash Flow Report. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. 0 Great. International Markets. no point selling now. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself,Publication of Invex IIH Phase II Pressure Trial Results. , page-4. , page-3. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. Created with Sketch. Trading HaltCreated with Sketch. . IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. 1. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. Transparency is our policy. ASX - Short Term Trading. 26 area could be wrong and it could go for example to $3. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. IXC needs to be proactive and release a statement. . 59). Update - Notification regarding unquoted securities - IXC. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. **Close price adjusted for splits and dividend and/or capital gain distributions. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. 91%) As of 03:35PM EST. Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-3. . , page-2. June 15 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES WRITTEN RESPONSE FROM FDA ON TYPE C MEETING ON PHASE III CLINICAL TRIAL DESIGN FOR. . Given the quality of the posters on the IXC thread I am confident others will do the same. Top Smart Score Stocks. ASX - By Stock. Most bio's get acquired on P2 readouts, if results are strong early here. 147,415. Strong buy side, sell side still very thin. . Created with Sketch. 76 (-1. 0. Share Not unexpected. Last updated 15. Share I've got no issues with it. Folks say we are pioneers of craft ice cream in Victoria. AX stock on. Of course, IXC’s BoD need to win back credibility for the market to more fairly value IXC’s TBI ODD… Having gone through the roller-coaster over the past one week, with my emotions now settled – I will be (slowly) buying-up in. Postcard to ShareholdersIXC (ASX) Ann: Trading Halt - HotCopper. $45M MC $30M Cash and a $1. Forums. IXC. Invex Therapeutics Lists on ASXNo worries mate :), page-15. Top 20 remains holding 58% compared to 58. ASX - Day TradingTo name a few other biotechs that have gotten belted by the market of the last few months that have had decent bounces such as NOX, NYR and PEB. ASX - Day TradingHere's a very good opportunity for people in Sydney. Mernova, a subsidiary of Melodiol Global Health (ASX:ME1), is on track to achieve its highest ever monthly sales, with revenues expected to reach A$891,944 in October 2023. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. . ASX - Day Trading. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Forums. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Australian finance news, stock quotes, currency information and blogs Active Funds. Market Cap $102. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited) At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Last updated 15. IXC Price at posting: 45. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. . Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Invex Files Pre-IND/Type B Meeting Request with US FDA IXC is a long term play mate, not a daytraders plaything as too illiquid. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. These are 2007 numbers. Charts. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Met primary endpoints for phase 2 trials. AVALANCHE. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. When can we expect some update or. IXC below Example of that is NEU Investor Presentation, page-3. . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. 6million shares?, and if so is anyone worried about this, release date 29th. ASX - By Stock. . a shell trading below cash backing, ripe. Forums. ASX - By Stock. Created with Sketch. . ASX - Short Term Trading. ASX - Day TradingIf anyone told me a year ago, "there is a chance IXC cant progress the trial and the management all get sacked" I would agree that there was a chance, but nullified to a 1-2% black swan and worth the upside return profile. *Close price adjusted for splits. $100-200k might be the minimum for the market to take notice. Latest Posts Forums iShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. 00 over the course of 2 years, and then doubled to $14 overnight on FDA approval. Market . The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Created with Sketch. Discover historical prices for IXC. Thought that this would be worthy of its own thread, a great starting place for those new to IXC and arguably the best presentation to date, Worth a. Zillow has 23383 homes for sale in British Columbia. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Latest Posts. The Chart: An Opportunity at these Levels?Timeline Annotations of the IXC Chart Story Thus Far- IXC IPO'd in mid 2019 with Phase II data due Mid 2020,. Below is the broker data for IXC November to. , page-17. It certainly has been a hard few months for the biotech sector with PEB, NYR, NOX and now IXC all having prangs. ASX - By Stock. 3. A neurosurgeon from Mercer Island and a noted mountaineer from Spokane, Washington, were killed on February 4, 1986, when. 026. , page-4. Last edited by jellyroll: 27/02/23. 1950. . 50%. . ASX - By Stock. Here come the vultures. Created with Sketch. , page-4. 15M !Invex to Present at Bell Potter Healthcare ConferenceNotice of Annual General Meeting/Proxy Form, page-3. Invex to Present at Upcoming Tech Biotech Broker BriefingCreated with Sketch. The IXC stock may trade low due to this wider macroeconomic issues, but the business itself is top 5% to its peers merely from the fact of having no future funding requirements and that if the trial is a success having close to immediate revenues and default alive status via Peptron manufacturing contract fulfilling demand on potential FDA. 0¢ Sentiment: Buy Disclosure: Held. Very tempted to buy them back today at 19c. Charts. Charts. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - By Stock. . ASX - By Stock. Anyone had a look at this or put an application in for some stock in the IPO?, page-2. Market . Created with Sketch. Created with Sketch. Forums. , page-32. Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. I think having this out we can discuss on the way. Below is the broker data for IXC November to. 5¢ Sentiment: Buy Disclosure: Held. sentiment based on opinions from HotCopper and others. ASX - By Stock. With a team of 68. 10 cents a week and we will be at $2 plus in no time. ASX - By Stock. A handy 10 bags from here with seemingly little risk. Forums. 0¢ Sentiment: Buy Disclosure: Held. . , page-5. Investor PresentationI would be worried about holding IXC if they had no more cash. Appendix 4E and Annual Report, page-3. Although, IXC is trading about 3-4x lower than what I expect it to be. Join the HotCopper ASX share market forum today for free. ASX - General. EGREcoGraf partners with VinES Energy for pioneering Battery Anode Material Facility in Vietnam. Charts. Latest Posts. Latest Posts. Created with Sketch. . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-5. ASX - General. ASX - Day TradingCreated with Sketch. Share A few weeks ago in the lead up to the Phase 2 results invex included this slide on their slide deck - 'average 42 million increase in market cap after positive Phase 2 results'. 333334. Created with Sketch. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. Initial FDA and EMA Advice on Presendin Development, page-3. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. is 19. 30 Haven’t supported share price since then on market . pause in tradingHere we go! AU and UK sites activated for immediate recruitment. , page-4. ASX - Day TradingAs thread states post your questions here and let’s start compiling a list. Latest Posts. 5% last year. US data averaged $2314 per person in direct medical care, the total average direct cost per IIH admission was 4x that or $9256. Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. Market . The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. . 5¢ Sentiment: Buy Disclosure: Held Ive compared IXC to NEU before and believe we approx. 0¢ Sentiment: Buy Disclosure: Held. ASX - Day Trading. 3¢. Join the HotCopper ASX share market forum today for free. ASX - Day TradingApril 20 (Reuters) - Invex Therapeutics Ltd (IXC) : MINISTRY OF HEALTH APPROVAL FOR IIH EVOLVE CLINICAL TRIAL IN ISRAELInvestor Presentation, page-2. Both approaches can work, but it is not wise to confuse the two. . ASX - By Stock. IXC Price at posting: $1. Charts. LATEST NEWS: Toubani Resources releases MRE update for Kobada gold project, Mali. Get the edge as an investor: Subscribe to our daily newsletter for EXCLUSIVE insights into HotCopper!. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Management ticking boxes while shareholders continue to have a golden opportunity to invest near all time lows in a company that has continually de-risked the fundamentals thesis. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. Probably been disappointed like all of usCreated with Sketch. Created with Sketch. Market open. Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. ASX - Day Trading. 7% #asx #ausbiz 23 Jun 2023 06:06:11. ASX - Day Trading. , page-2. Some people like to gamble on stocks, others invest. Spot on - filled the 1. . My. ASX - Day Trading0. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. Target our investor community with our suite of Hotcopper Advertising opportunities. Charts. Loading. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Forex. IAMIncome Asset Management to boost bond sales through partnership with Netwealth. RAC went from 30 cents to $4 in the space of 5 months PAR went from 30 cents to $4 in the space of 1 and half years NEU went from $1. But lets not talk about NSB here, we are here to see progress with IXC. ASX - Day Trading. Advertise on HotCopper. Most bio's get. I bought the chart from base lows looking for a trade. That is fair and as I mentioned in my initial post when buying, the business is worth the cash in ST. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - General. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. . ASX - By Stock. Join the HotCopper ASX share market forum today. . 5 cents. Currency in USD 38. Notice of Investor Call and Presentation, page-2. , page-2. Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Advertise on HotCopper. ASX - General. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. Advertise on HotCopper. IXC (ASX) Ann: Trading Halt - HotCopper. IXC current EV is close to $0 so again Im not sure what OSL valuation is but I dont think it stacks up as good as IXC and where IXC is at in its timeline. ASX - By Stock. ASX - By Stock. Bumping up this thread as $3. , page-5. Only took that large seller to sell, now liquidity has dried up and. ASX - Day TradingWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. Share 14 mill MC 22 mill cash Like I said they might have gotten rid of Jason and Alex to streamline costs, smartest thing to do is JV with some large pharma let them run trials we get 40% royalty and they get 60% of drug (sell it to them). ASX - Short Term Trading. Market . . Created with Sketch. ASX - Day TradingI bought some today at 44. Discover historical prices for IXC. 375,000. Join the HotCopper ASX share market forum today for free. Forums. Forums. com. Hopefully that placement overhang will be removed today tomorrow and the share price will catch up. Withdrawal of AGM Resolutions, page-2. . Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. . 0% $ODM 35. Notice of Investor Call and Presentation, page-3. 1. ASX - By Stock. Sentiment for Invex Therapeutics Ltd. IXC Price at posting:. . . Share Appreciate the commentary and post. HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Join the HotCopper ASX share market forum today for free. 0. Created with Sketch. Appreciate your input Dr T. Target our investor community with our suite of Hotcopper Advertising. Latest Posts. Withdrawal of AGM ResolutionsInvex Granted Key European Patent for Exenatidehe’s known for the vend etc like asxcowboy has pointed out. 26 area could be wrong and it could go for example to $3. Notification of cessation of securities - IXC. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. Last edited by ejjwj: 28/06/23. Orphan drug status. Invex issued US patent for Traumatic Brain Injury. , page-3. ASX - Day Trading. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. In 2005, IIH cost the American health care. gov and there is lots of good information about the trial. Latest Posts. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. 43 Sentiment: Buy Disclosure: Held. ASX - By Stock. Plans & Pricing. Market . Forums. We are a team of expert financial advisers each specialising in different, yet complementary areas. , page-136. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. Created with Sketch. 00% 21. ASX - By Stock. . Market . 06KBNotification of cessation of securities - IXC. ASX - By Stock. Andrew Forrest , or his entities have been involved with IXC since inception. Join the HotCopper ASX share market forum today for free. ASX - By Stock. British Columbia, Selkirk Mountains. . Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Market . Market . " Seems a bit rough, anyone would think they are trying to minimise the number of SH who 'attend' the AGM. . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. But posts 3-4 times a day that are the same charts we can all see, about a -3% move on $10k volume, paired with hysteria and paranoia, its just not. So it seems that as of 18 July the trials are still recruiting! An update was submitted to this site 3 days. ASX - Day TradingAnother day…another approval. . 8 Upvote Created with Sketch. Australian finance news, stock quotes, currency information and blogs0. ASX - Short Term Trading. So your thesis is right on a long time time frame. Created with Sketch. **Close price adjusted for splits and dividend and/or capital gain distributions. IXC Price at posting: 44. Umbrella Society is a proud Living Wage Employer! Greater Victoria's official living wage has been adjusted to $25. 2 Upvote. This was roughly 50/50 between lost wages and direct medical costs. Share “Exercise Price Subject to paragraph (j), the amount payable upon exercise of each Option will be the 50% premium to the 30 day VWAP immediately prior to the Meeting (Exercise Price). Join the HotCopper ASX share market forum today for free. Created with Sketch. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. . Just unfortunate to hit the black swan so badly here, both the. 10 Upvote. ASX - By Stock. Created with Sketch. Therefore Id bet the same bet with the same info again. I find this very intriguing and positive that in last few weeks about 1. Backed by Twiggy. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. . 50%. Charts. ASX - Short Term Trading. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication.